Insights

Regulatory risk Alvogen is facing legal scrutiny in Colorado over alleged unfair or deceptive practices related to opioid sales and internal monitoring lapses. This creates a potential risk profile for supply continuity and compliance, suggesting a sales opportunity to position higher-trust sourcing, transparency commitments, and robust compliance support for customers and partners.

Strategic partnerships Recent license and development deals with Solaxa for SLX-100 indicate Alvogen’s openness to co-development and worldwide commercialization partnerships. This presents an entry point to offer complementary research, development, and regional expansion support, as well as portfolio licensing opportunities for distributors and risk-sharing agreements.

Expanded manufacturing With significant in-house manufacturing capacity in Norwich, NY and a broad US footprint, Alvogen can be targeted for contract manufacturing, scale-up collaborations, and supply guarantees for high-demand generics, particularly in oncology and specialty medications.

Diversified portfolio The launch of Enzalutamide in Korea and ongoing generic oncology products demonstrate a focus on high-value, patent-expiry opportunities. This suggests upsell potential to healthcare systems and payers for affordable oncology generics, as well as entry points to hospital networks and regional distributors.

Financial scale Revenue is reported in the range of one to ten billion with substantial funding, indicating a mature, scalable platform. This supports pursuing larger, multi-country distribution agreements, strategic investments in quality and regulatory compliance services, and long-term procurement partnerships with health systems and wholesalers.

Similar companies to Alvogen

Alvogen Tech Stack

Alvogen uses 8 technology products and services including AutoCAD, Amazon Web Services, Amazon Simple Email Service, and more. Explore Alvogen's tech stack below.

Media & News

Alvogen's Email Address Formats

Alvogen uses at least 3 email formats:
Alvogen Email FormatsExamplePercentage
First.Last@alvogen.comJohn.Doe@alvogen.com
95%
FLast@alvogen.comJDoe@alvogen.com
4%
First.Middle@alvogen.comJohn.Michael@alvogen.com
1%

Frequently Asked Questions

What is Alvogen's phone number?

Minus sign iconPlus sign icon
You can contact Alvogen's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Alvogen's official website and social media links?

Minus sign iconPlus sign icon
Alvogen's official website is alvogen.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Alvogen generate?

Minus sign iconPlus sign icon
As of October 2026, Alvogen's annual revenue is estimated to be $1B - $10B.

What is Alvogen's SIC code and NAICS code?

Minus sign iconPlus sign icon
Alvogen's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Alvogen have currently?

Minus sign iconPlus sign icon
As of October 2026, Alvogen has approximately 476 employees across 3 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: L. G., Chief Executive Officer: R. L. and Cfo Alvogen Korea: S. P. Explore Alvogen's employee directory with LeadIQ.

What industry does Alvogen belong to?

Minus sign iconPlus sign icon
Alvogen operates in the Pharmaceutical Manufacturing industry.

What technology does Alvogen use?

Minus sign iconPlus sign icon
Alvogen's tech stack includes AutoCAD, Amazon Web Services, Amazon Simple Email Service, ADP Workforce Now, Microsoft Entra ID, Coupa, SAP Concur and Adobe Creative Suite.

What is Alvogen's email format?

Minus sign iconPlus sign icon
Alvogen's email format typically follows the pattern of First.Last@alvogen.com. Find more Alvogen email formats with LeadIQ.

How much funding has Alvogen raised to date?

Minus sign iconPlus sign icon
As of October 2026, Alvogen has raised $769M in funding. The last funding round occurred on Mar 07, 2025 for $669M.

When was Alvogen founded?

Minus sign iconPlus sign icon
Alvogen was founded in 2009.
Alvogen logo

Alvogen

Pharmaceutical ManufacturingNew Jersey, United States201-500 Employees

Alvogen is a United States-based pharmaceutical manufacturing company focused on developing, in-licensing, manufacturing, and marketing pharmaceutical products. The company is headquartered in Morristown, New Jersey, with a street address at 44 Whippany Road, Morristown, 07960. It employs 201-500 people and has significant in-house manufacturing capacity in Norwich, New York. Alvogen operates in the pharmaceutical industry and maintains a corporate website at https://alvogen.com. Recent news indicates development and licensing activities with third parties related to SLX-100.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
201-500

Section iconFunding & Financials

  • $769M

    Alvogen has raised a total of $769M of funding over 4 rounds. Their latest funding round was raised on Mar 07, 2025 in the amount of $669M as a Debt Financing.

  • $1B - $10B

    Alvogen's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.